|
Index of reports
> Cases resulting in life threatening events (27)
> Cases with Dyspnoea (3)
Below is the selection of adverse event reports related to Cozaar (Losartan) that includes cases resulting in life threatening events where reactions include dyspnoea.
Adverse event in 56 year old female receiving Cozaar (Losartan)
Reported by a physician from Norway on 2007-10-24
Patient: 56 year old female
Adverse reactions / side effects: Dyspnoea, Hyponatraemia, Obstructive Airways Disorder, Generalised Oedema
Adverse event resulted in: life threatening event
Suspect drug(s):
Brexidol
Administration route: Oral
Indication: Arthralgia
Cozaar
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
Diural
Dosage: 40 mg, qd
Administration route: Oral
Indication: Oedema
Start date: 2007-08-28
Ibux
Indication: Arthralgia
Start date: 2007-08-01
Naproxen
Administration route: Oral
Indication: Arthralgia
Voltaren
Dosage: 50 mg, tid
Administration route: Oral
Indication: Arthralgia
Start date: 2007-08-01
Other drugs received by patient: Pinex Forte; Doxylin; Vival; Noni Juice; Pinex; Fenazon-Koffein
Adverse event in 17 year old male receiving Cozaar (Losartan)
Reported by a individual with unspecified qualification from United States on 2007-10-10
Patient: 17 year old male, weighing 77.6 kg (170.6 pounds)
Adverse reactions / side effects: Movement Disorder, Dyspnoea, Abasia, Hypoaesthesia, Fall, Convulsion, Pulse Absent, Unevaluable Event, Cardiac Arrest, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Cozaar (Losartan)
Adverse event in 77 year old male receiving Cozaar (Losartan)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-01-26
Patient: 77 year old male, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Chest Discomfort, Dyspnoea, Atrial Flutter
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Cozaar
Administration route: Oral
Indication: Hypertension
Start date: 2001-01-01
Sildenafil Citrate
Administration route: Oral
Indication: Pulmonary Hypertension
Start date: 2006-09-13
End date: 2006-09-15
Other drugs received by patient: Nebivolol Hydrochloride; Nebivolol Hydrochloride
|
